GeneDx Holdings Corp. (WGS) Insider Trading
- $4,263,232.78
- $108,382,920.77
- Dec. 16, 2024
- Kevin Feeley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 16, 2024 | CFO | 3,728 | $76.75 | Sell | $286,124.00 | |
Dec. 16, 2024 | CEO | 10,501 | $76.75 | Sell | $805,951.75 | |
Dec. 9, 2024 | CEO | 3,661 | $76.37 | Sell | $279,590.57 | |
Dec. 9, 2024 | CFO | 1,137 | $76.37 | Sell | $86,832.69 | |
Dec. 2, 2024 | CFO | 263 | $78.39 | Sell | $20,616.57 | |
Nov. 21, 2024 | CFO | 12,019 | $73.76 | Sell | $886,521.44 | |
Nov. 19, 2024 | Director | 31,510 | $71.28 | Sell | $2,246,032.80 | |
Nov. 18, 2024 | Major Shareholder | 126,782 | $70.78 | Sell | $8,973,629.96 | |
Nov. 18, 2024 | CEO | 22,307 | $70.34 | Sell | $1,569,074.38 | |
Nov. 15, 2024 | Major Shareholder | 20,359 | $69.78 | Sell | $1,420,651.02 | |
Nov. 15, 2024 | CEO | 23,108 | $70.48 | Sell | $1,628,651.84 | |
Oct. 31, 2024 | Major Shareholder | 865,800 | $75.00 | Sell | $64,935,000.00 | |
Oct. 29, 2024 | CEO | 2,154 | $66.60 | Sell | $143,456.40 | |
Oct. 29, 2024 | CFO | 274 | $66.60 | Sell | $18,248.40 | |
Sept. 9, 2024 | CEO | 3,639 | $33.33 | Sell | $121,287.87 | |
Sept. 9, 2024 | CFO | 895 | $33.33 | Sell | $29,830.35 | |
Sept. 3, 2024 | CFO | 262 | $31.71 | Sell | $8,308.02 | |
Aug. 19, 2024 | Major Shareholder | 50,000 | $34.49 | Sell | $1,724,500.00 | |
Aug. 15, 2024 | Major Shareholder | 39,824 | $33.08 | Sell | $1,317,377.92 | |
Aug. 12, 2024 | Major Shareholder | 59,787 | $33.95 | Sell | $2,029,768.65 | |
Aug. 8, 2024 | Major Shareholder | 100,000 | $31.82 | Sell | $3,182,000.00 | |
Aug. 6, 2024 | Major Shareholder | 12,994 | $29.35 | Sell | $381,373.90 | |
July 31, 2024 | Major Shareholder | 88,839 | $33.50 | Sell | $2,976,106.50 | |
July 29, 2024 | Major Shareholder | 50,000 | $33.86 | Sell | $1,693,000.00 | |
July 29, 2024 | CEO | 2,154 | $33.54 | Sell | $72,245.16 | |
July 29, 2024 | CFO | 274 | $33.54 | Sell | $9,189.96 | |
July 26, 2024 | Major Shareholder | 60,000 | $33.85 | Sell | $2,031,000.00 | |
July 24, 2024 | Major Shareholder | 75,000 | $33.72 | Sell | $2,529,000.00 | |
July 22, 2024 | Major Shareholder | 50,000 | $32.61 | Sell | $1,630,500.00 | |
July 19, 2024 | Major Shareholder | 25,000 | $32.29 | Sell | $807,250.00 | |
July 17, 2024 | Major Shareholder | 25,000 | $32.93 | Sell | $823,250.00 | |
July 5, 2024 | Major Shareholder | 36,118 | $28.24 | Sell | $1,019,972.32 | |
July 3, 2024 | Major Shareholder | 14,082 | $28.23 | Sell | $397,534.86 | |
July 1, 2024 | Major Shareholder | 50,000 | $26.63 | Sell | $1,331,500.00 | |
June 17, 2024 | CFO | 2,646 | $28.31 | Sell | $74,908.26 | |
June 17, 2024 | CEO | 7,683 | $28.31 | Sell | $217,505.73 | |
June 10, 2024 | CFO | 895 | $24.92 | Sell | $22,303.40 | |
June 10, 2024 | CEO | 2,652 | $24.92 | Sell | $66,087.84 | |
June 3, 2024 | Director | 100,000 | $20.82 | Buy | $2,082,000.00 | |
May 28, 2024 | Director | 18,304 | $20.61 | Buy | $377,245.44 | |
May 23, 2024 | Director | 7,500 | $19.59 | Buy | $146,925.00 | |
May 13, 2024 | Director | 50,000 | $23.31 | Buy | $1,165,500.00 | |
April 29, 2024 | CEO | 6,325 | $11.04 | Sell | $69,828.00 | |
April 29, 2024 | CFO | 1,104 | $11.04 | Sell | $12,188.16 | |
March 18, 2024 | Insider | 2,008 | $10.59 | Sell | $21,264.72 | |
March 18, 2024 | CEO | 8,559 | $10.59 | Sell | $90,639.81 | |
March 18, 2024 | CFO | 3,253 | $10.59 | Sell | $34,449.27 | |
March 4, 2024 | Director | 40,000 | $8.74 | Buy | $349,600.00 | |
Jan. 22, 2024 | Insider | 193 | $3.24 | Sell | $625.32 | |
Jan. 3, 2024 | Insider | 105 | $2.58 | Sell | $270.90 |
Insiders are both buying and selling GeneDx Holdings Corp. stock.
The insider traders at GeneDx Holdings Corp. are: Kevin Feeley, Katherine Stueland, Opko Health, Inc., Kareem Saad, Karen Ann White, Casdin Capital, Llc, Jason Ryan, Richard C Pfenniger Jr, and School Of Medicine At Mo Icahn
The most active insider trader at GeneDx Holdings Corp. is Kevin Feeley with 22 trades.
School Of Medicine At Mo Icahn has sold the most GeneDx Holdings Corp. stock with a total value of $84,302,910.94.
Casdin Capital, Llc has bought the most GeneDx Holdings Corp. stock with a total value of $6,203,270.44.
The most recent insider trade for GeneDx Holdings Corp. was on Dec. 16, 2024.
The single biggest insider buy for GeneDx Holdings Corp. was from Casdin Capital, Llc with a total value of $2,082,000.00 on June 3, 2024.
The single biggest insider sell for GeneDx Holdings Corp. was from School Of Medicine At Mo Icahn with a total value of $64,935,000.00 on Oct. 31, 2024.